SERPINC1, also known as antithrombin, is a gene that encodes a protein which plays a key role in regulating blood clot formation. Mutations in the SERPINC1 gene can lead to antithrombin deficiency, a condition that increases the risk of developing blood clots and can potentially result in thrombosis. Research in the field of serpinc1 focuses on understanding the mechanisms of antithrombin function, the impact of mutations on its activity, and potential therapeutic strategies for treating antithrombin deficiency. This research is important for improving our understanding of blood clotting disorders and developing new treatments for these conditions.